Featured StoryEditor's Pick
Latest Articles
Sunscreen, Chemical vs Mineral, and What the FDA Actually Changed: A Practical Look at the Evidence
The sunscreen conversation has changed substantially in the past few years. JAMA studies confirmed that common chemical sunscreen ingredients are absorbed into the bloodstream at concentrations far above the FDA's safety-evaluation threshold. The FDA proposed that only zinc oxide and titanium dioxide be classified as Generally Recognized as Safe and Effective. The EU restricted oxybenzone in body products in 2022. Through all of this, the fundamental case for using sunscreen — that daily use prevents melanoma and squamous cell carcinoma — has only gotten stronger. Here is what the evidence actually shows.
A Familiar Product, A More Complicated Picture
For most of the past several decades, the sunscreen conversation was simple. Sunscreen prevents skin cancer; you should use it; SPF 30 is the rough floor; reapply every two hours. The choice between "chemical" and "mineral" formulations was a matter of cosmetic preference — chemical sunscreens went on clear and felt light, mineral sunscreens (zinc oxide, titanium dioxide) left a white cast but were considered slightly gentler on sensitive skin.
That simple framing has become harder to defend in the past few years. Two large FDA-funded studies confirmed that common chemical sunscreen ingredients are absorbed through the skin and into the bloodstream at concentrations far higher than the agency's safety-evaluation threshold. The FDA's 2019 proposed rule, carried forward into a 2021 administrative order, concluded that only two of the 16 currently marketed sunscreen ingredients had sufficient safety data to be classified as Generally Recognized as Safe and Effective. The European Union concluded that one of the most-used chemical filters, oxybenzone, was not safe at historical concentrations and restricted it. Through all of this, the fundamental case for using sunscreen has gotten stronger, not weaker — the gold-standard randomized trial of daily sunscreen use shows substantial reductions in skin cancer. The right answer is not "stop using sunscreen." It is "use the formulations the evidence currently supports, while the chemical-filter safety questions get worked out."
What "Chemical" and "Mineral" Sunscreens Actually Are
The distinction between chemical and mineral (sometimes called physical) sunscreens is real but more nuanced than the marketing suggests.
Chemical sunscreens contain organic molecules — typically avobenzone, oxybenzone (benzophenone-3), octocrylene, homosalate, octisalate, and octinoxate — that absorb ultraviolet radiation and dissipate it as heat. These ingredients are highly effective at preventing UV penetration into the skin, are usually cosmetically elegant (they apply clear and feel light), and have been the dominant formulation type in the US market for several decades. The chemistry that makes them effective — small molecules that interact electronically with UV photons — also makes them small enough to potentially cross the skin barrier and enter systemic circulation.
Mineral sunscreens contain two inorganic ingredients: zinc oxide and titanium dioxide. These work primarily by sitting on the skin surface and physically scattering and absorbing UV radiation. Their larger particle size means they do not penetrate the skin barrier in any meaningful quantity. The trade-off is cosmetic: older mineral sunscreens left a noticeable white cast on the skin, particularly on darker skin tones. Modern formulations using micronized zinc oxide and titanium dioxide have substantially reduced this issue, though some white cast tends to remain.
What the FDA Studies Actually Found
In 2019 and 2020, Murali Matta and colleagues at the FDA published two studies in JAMA examining what happens when people apply common chemical sunscreens under typical maximum-use conditions: 2 milligrams of sunscreen per square centimeter applied to 75% of body surface area, four times daily for four days. The 2020 study, the more comprehensive of the two, involved 48 healthy participants randomized to one of four product formulations (lotion, aerosol spray, non-aerosol spray, or pump spray) and measured plasma concentrations of six active ingredients [1].
The findings were striking. The FDA had previously established 0.5 nanograms per milliliter as the plasma threshold above which safety studies would be required for a topically applied drug — a precautionary level chosen to be conservative. All six chemical sunscreen ingredients tested — avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate — exceeded the 0.5 ng/mL threshold after a single application [1]. For most ingredients, the threshold was crossed within hours of the first application, and concentrations continued to rise with repeated daily use. Oxybenzone reached geometric mean maximum plasma concentrations of 258 ng/mL for the lotion formulation and 180 ng/mL for the aerosol spray — between 360 and 516 times the FDA's safety-evaluation threshold.
The authors were explicit about an important caveat: the study did not assess whether the absorbed quantities cause any harm. It documented absorption — a necessary first step for evaluating long-term safety — but did not establish that these systemic exposures translate into health effects in real-world use. The authors specifically concluded that the findings "do not indicate that individuals should refrain from the use of sunscreen" while the safety question was being worked out [1]. The absorption data did, however, tell regulators that the safety-data void for these ingredients needed to be filled.
How the FDA Responded
The FDA's regulatory response, articulated in the 2019 proposed rule and carried forward in a 2021 administrative order, was that of the 16 sunscreen ingredients then on the US market, only zinc oxide and titanium dioxide had sufficient evidence to be classified as Generally Recognized as Safe and Effective (GRASE) [2]. Two ingredients no longer in commercial use (PABA and trolamine salicylate) were classified as Not GRASE. The remaining 12 — including all the common chemical filters consumers actually buy — were classified as Category III: insufficient data to determine GRASE status, with the FDA requesting additional safety data from manufacturers, particularly on systemic absorption, irritation, sensitization, and reproductive and developmental toxicity [2].
This is a specific regulatory technicality worth understanding. Category III is not a ban or a finding of unsafety. The absence of GRASE classification does not mean the ingredients are unsafe — it means the safety data available does not meet the modern threshold the agency would apply to a newly approved topical drug, in light of the new absorption findings. Manufacturers continue to market these ingredients under enforcement discretion while the data is being assembled, and the FDA has not recommended that consumers avoid them.
A separate practical consequence: because the FDA's review backlog has historically been slow, the US sunscreen market has not added a new chemical filter in roughly 20 years, while the EU, Asia, and Australia have approved several newer-generation filters with better safety profiles and better photostability. The 2025-2026 approval of bemotrizinol — the first new chemical filter added to the US monograph in two decades — is the first sign of meaningful modernization.
What the EU Did Differently
The European Union's regulatory approach is structured differently and produced a different conclusion on at least one widely used ingredient. In March 2021, the EU's Scientific Committee on Consumer Safety concluded that oxybenzone was not safe for consumer use as a UV filter at the historical 6% concentration limit in body sunscreens, citing concerns about endocrine-disrupting potential. In July 2022, the European Commission adopted Regulation 2022/1176, restricting oxybenzone to a maximum of 2.2% in body sunscreens and creams (and up to 6% only in face, hand, and lip products where total exposure is lower), with the regulation taking full effect in 2023 [3]. In September 2025, the European Chemicals Agency formally identified oxybenzone as an endocrine disruptor for both human health and the environment, with further regulatory restrictions expected.
The US has not banned or restricted any chemical filter; the EU restricted one based on a specific safety assessment. This divergence — same ingredient, two regulators, two different conclusions — reflects the underlying state of the evidence: the systemic absorption is established, the long-term health implications are not, and reasonable regulators can weight the precautionary considerations differently.
What the Evidence Does and Doesn't Say About Health Effects
It is worth being clear about what the absorption findings do and do not tell us. The Matta studies established that chemical sunscreen ingredients enter systemic circulation at concentrations above the FDA's data-trigger threshold. They did not establish that these systemic exposures cause adverse health effects in real-world use.
Subsequent investigation of specific concerns — endocrine effects, particularly on thyroid and reproductive hormones — has been mixed. Some observational studies have reported associations between higher urinary biomarkers of oxybenzone exposure and altered thyroid or reproductive hormone levels; other studies have not. The mechanistic plausibility (oxybenzone interacts with estrogen receptors at high concentrations in laboratory studies) is established, but the in-vivo relevance at the exposures that arise from typical sunscreen use is genuinely unclear. This is the kind of evidence gap that regulators try to close before issuing strong public-health recommendations.
What is established is that mineral sunscreens — zinc oxide and titanium dioxide — do not produce the systemic absorption that drives the safety questions. They sit on the skin surface and do not enter systemic circulation in meaningful quantities. This is the principal reason the FDA classified them as GRASE while flagging the chemical filters for additional data [2].
The Crucial Other Side: Sunscreen Genuinely Prevents Skin Cancer
In the noise of the chemical-filter debate, the fundamental case for using sunscreen is often lost. The best-quality randomized evidence on sunscreen and skin cancer comes from the Nambour Skin Cancer Prevention Trial, conducted in Queensland, Australia — a high-UV environment where 1,621 adults were randomized to either daily SPF 15+ sunscreen application to head and arms or discretionary use, between 1992 and 1996, with extended follow-up to 2006. At the 10-year follow-up published in the Journal of Clinical Oncology in 2011, the daily-sunscreen group had developed 11 primary melanomas versus 22 in the discretionary-use group — a reduction of roughly 50% in melanoma incidence [4]. Earlier analyses from the same trial had also documented a 60% reduction in squamous cell carcinoma incidence [4].
This is the gold-standard evidence on sunscreen and skin cancer prevention. Skin cancer remains the most common cancer in the US, and melanoma rates have continued to rise across all age groups including young adults. Whatever questions exist about specific chemical filters, the fundamental case for regular sunscreen use is supported by RCT evidence and is not in dispute.
A Practical Synthesis
For the consumer confused by years of conflicting reporting, the practical position is straightforward.
**Use sunscreen.** The skin cancer prevention case is well established by randomized trial evidence [4]. Daily broad-spectrum SPF 30 or higher applied to sun-exposed areas, with reapplication every two hours during prolonged sun exposure, is the well-supported standard.
**Prefer mineral sunscreens (zinc oxide, titanium dioxide) where they work for you.** These are the formulations the FDA has affirmed as GRASE, and they do not produce systemic absorption. Modern micronized zinc oxide formulations have substantially reduced (though not eliminated) the white-cast issue that historically made mineral sunscreens harder to use on darker skin tones.
**If you use chemical sunscreens, you are not doing something dangerous.** The absorption data is real; the health-effect data is not yet clear. The FDA has not recommended that consumers stop using chemical filters, and the underlying skin-cancer-prevention benefit far outweighs any plausible risk from systemic absorption at currently understood levels. If you specifically want to avoid oxybenzone — the filter with the strongest endocrine-disruption signal and the EU restriction — that is a reasonable precautionary choice [3], but not an evidence-based necessity.
**Children and pregnancy.** For infants under six months, sun avoidance, shade, and physical barriers (hats, clothing) are preferred over sunscreen of any kind. For children over six months and during pregnancy, mineral sunscreens are the more conservative choice given the unsettled chemical-filter safety data, though no specific harm from chemical filter use has been established at the relevant exposures.
For specific concerns — particularly endocrine conditions, pregnancy, or chronic skin conditions — talking to a dermatologist about your specific situation is the most useful path. The basic message is unchanged: skin cancer kills, sunscreen helps, and choosing the formulation the evidence currently supports is straightforward.
Further Reading
Matta M.K., Florian J., Zusterzeel R. et al. — Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial (JAMA, 2020) — full FDA-funded study in 48 participants showing all six chemical filters (avobenzone, oxybenzone, octocrylene, homosalate, octisalate, octinoxate) exceeded the FDA's 0.5 ng/mL plasma threshold after a single application
jamanetwork.com
U.S. Food and Drug Administration — Sunscreen Drug Products for Over-the-Counter Human Use: Proposed Order (Monograph M020) — 2021 FDA proposed administrative order continuing the 2019 proposed-rule positions that only zinc oxide and titanium dioxide have sufficient safety evidence to be classified as Generally Recognized as Safe and Effective (GRASE)
fda.gov
Commission Regulation (EU) 2022/1176 — amending the Cosmetics Regulation (EU) 1223/2009 to restrict the use of Benzophenone-3 (oxybenzone) and Octocrylene as UV filters based on Scientific Committee on Consumer Safety findings on endocrine-disrupting potential
eur-lex.europa.eu
Green A.C., Williams G.M., Logan V., Strutton G.M. — Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up (Journal of Clinical Oncology, 2011) — 10-year follow-up of the Nambour Skin Cancer Prevention Trial showing daily SPF 15+ sunscreen use roughly halved subsequent melanoma incidence in 1,621 Australian adults
ascopubs.org
📢 Advertisement — In-Article Ad